Table 2. Antibacterial Action of Fe–CdO.
| samples | inhibition
zone (mm)a |
inhibition
zone (mm)b |
||
|---|---|---|---|---|
| 500 μg/50 μL | 1000 μg/50 μL | 500 μg/50 μL | 1000 μg/50 μL | |
| 1:0 | 0.9 ± 0.01 | 1.65 ± 0.02 | 0 ± 0.0 | 2.05 ± 0.02 |
| 1:2 | 1.1 ± 0.05 | 2.15 ± 0.04 | 1.95 ± 0.03 | 4.25 ± 0.03 |
| 1:4 | 1.25 ± 0.08 | 2.3 ± 0.05 | 2.4 ± 0.04 | 4.45 ± 0.05 |
| 1:6 | 1.4 ± 0.06 | 2.75 ± 0.07 | 2.65 ± 0.05 | 4.9 ± 0.06 |
| enrofloxacin | 4.30 ± 0.03 | 4.30 ± 0.03 | 7.0 ± 0.04 | 7.0 ± 0.04 |
| DIW | 0 ± 0.0 | 0 ± 0.0 | 0 ± 0.0 | 0 ± 0.0 |
a
Inhibition areas of Fe-doped CdO for Gram-negative bacteria.
b
Measurements of zones of inhibition (mm) against Gram-positive bacteria.